Notably, a memory phenotype (defined by CD62L+CD44+), which is associated with long-term tumor remission after CAR T-cell therapy55,56, was observed exclusively in the PER-treated group, but not in the control group (Supplementary Fig. 27i). This evidence concerns the gene SELL and neoplasm.